Nimodipine and Back pain - a phase IV clinical study of FDA data

Summary:

Back pain is reported as a side effect among people who take Nimodipine (nimodipine), especially for people who are female, 60+ old, also take Norvasc, and have Primary immunodeficiency syndrome.

The phase IV clinical study analyzes which people have Back pain when taking Nimodipine. It is created by eHealthMe based on reports of 1,319 people who have side effects when taking Nimodipine from the FDA, and is updated regularly.

What is Nimodipine?

Nimodipine has active ingredients of nimodipine. eHealthMe is studying from 1,330 Nimodipine users. Check the latest studies of Nimodipine.

What is Back pain?

Back pain is found to be associated with 3,199 drugs and 4,716 conditions by eHealthMe. Check the latest studies of Back pain.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

1,319 people reported to have side effects when taking Nimodipine.
Among them, 14 people (1.06%) have Back pain.

Among these 14 people:

What is the gender of people who have Back pain when taking Nimodipine? *

female: 78.57 %
male: 21.43 %

What is the age of people who have Back pain when taking Nimodipine? *

What are other drugs people take besides Nimodipine? *

Propafenone Hydrochloride: 4 people, 28.57%
Norvasc: 4 people, 28.57%
Methylphenidate Hydrochloride: 3 people, 21.43%
Metformin: 2 people, 14.29%
Jadenu: 2 people, 14.29%
Clopidogrel: 2 people, 14.29%
Xeljanz: 1 person, 7.14%
Lyrica: 1 person, 7.14%
Latanoprost: 1 person, 7.14%
Enoxaparin Sodium: 1 person, 7.14%

What are other side effects people have besides Back pain? *

Fatigue (feeling of tiredness): 7 people, 50.00%
Fever: 6 people, 42.86%
Pain: 5 people, 35.71%
Weight Increased: 5 people, 35.71%
Dyspnea (difficult or laboured breathing): 5 people, 35.71%
Joint Pain: 4 people, 28.57%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 4 people, 28.57%
General Physical Health Deterioration (weak health status): 4 people, 28.57%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 28.57%
Oxygen Consumption Decreased: 4 people, 28.57%

What are the existing conditions these people have? *

Primary Immunodeficiency Syndrome: 4 people, 28.57%
High Blood Pressure: 3 people, 21.43%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 14.29%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 14.29%
Diabetes: 2 people, 14.29%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 7.14%
Blood Pressure Abnormal: 1 person, 7.14%
Cardiac Disorder: 1 person, 7.14%
Carotid Artery Disease: 1 person, 7.14%
Epidural Anaesthesia: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Nimodipine and have Back pain?

- Check whether Back pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nimodipine:

Nimodipine (1,330 reports)

Back pain treatments and more:

Back pain (379,875 reports)

Browse all side effects of Nimodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Back pain:

Back pain (3,199 drugs)

Browse all the conditions that are associated with Back pain:

Back pain (4,716 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nimodipine (the active ingredients of Nimodipine) and Nimodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.